November 30, 2011

While sales figures for pharmaceuticals are frequently reported on, drugs for people's four-legged friends also are a money maker.

November 2, 2011

AmerisourceBergen on Tuesday recorded revenues of $20.4 billion for fourth quarter 2011 ended Sept. 30, up 3.5%. Diluted earnings per share increased 8% to 54 cents. For the year, AmerisourceBergen posted $80.2 billion in revenue, up 2.9%.

October 20, 2011

Bristol-Myers Squibb announced changes to its senior management team, including the appointment of its U.S. pharmaceuticals president.

October 19, 2011

PakSense has launched a new label that monitors time and temperature of such perishable items as food, vaccines, pharmaceuticals and biologics during distribution and storage.

September 13, 2011

First-quarter net sales for Hi-Tech Pharmacal's generic pharmaceuticals business increased by 52% to nearly $49 million, the drug maker reported.

September 12, 2011

It’s hard to disagree that generic drug companies have had a good run for the last several years. Branded drug companies developed a large number of drugs that proved highly effective at treating widespread medical conditions and became blockbusters, garnering billions of dollars in sales in the United States alone.

September 6, 2011

Impax Labs has appointed a new president of its generic pharmaceutical division.

August 24, 2011


A worldwide flood of counterfeit and unsafe medications is seeping into the United States and other developed countries via the Internet and porous borders, threatening public health and the security of the pharmaceutical supply chain.

June 2, 2011

A company that develops insulin-pump technology without tubing, such as the OmniPod insulin management system, has acquired a durable medical equipment distributor that specializes in direct-to-consumer sales of diabetes supplies.

June 1, 2011

Sandoz has launched generic versions of treatments for Alzheimer’s disease, the generic pharmaceuticals division of Swiss drug maker Novartis said Wednesday.

May 26, 2011

Drug maker Johnson & Johnson plans to file for regulatory approval for 11 new drugs between 2011 and 2015, the company said Thursday in relation to a meeting between J&J’s executive committee and investors.

April 26, 2011

Hospira had net sales of $1 billion during first quarter 2011, the generic drug maker said Tuesday.

April 25, 2011

The way chief executive R. David Yost sees it, AmerisourceBergen Corp.’s Good Neighbor Pharmacy program is a bulwark for independent pharmacists against the pressures of a brutally competitive pharmacy market and an unforgiving economy.


April 18, 2011

A U.S. drug maker and its Japanese partner have started a late-stage clinical trial of a drug for treating elevated phosphate levels in the body, the two announced Monday.

April 14, 2011

Despite a difficult economy and rising health costs, the benefits of an integrated pharmacy service were evident as CVS Caremark helped its pharmacy benefit manager clients — employers, health plans and third-party administrators — manage pharmacy costs, according to the company's annual "Insights Report."

March 31, 2011

The American Enterprise Institute for Public Policy Research on Monday published a working paper that identified $329 million in overspending as a result of underutilization of generics.

March 18, 2011

Bausch + Lomb on Friday appointed a clinical professor of ophthalmology to serve as the company's first-ever chief medical officer.

March 17, 2011

Commenting on a counterfeit pharmaceutical inter-agency working group report, the National Association of Chain Drug Stores stressed that it shares the goal of improving the public awareness of the risks posed from counterfeit drugs and unlawful online drug sellers, but expressed concern over the report's proposal to mandate a "track-and-trace" system in the United States, given the high cost it could pose for pharmacies.

February 17, 2011

Novartis on Thursday morning named Naomi Kelman head of the Novartis OTC division, effective March 2. She will report directly to Joseph Jimenez, Novartis CEO.

February 10, 2011

This year’s upcoming $29 billion wave of margin-friendly generic pharmaceuticals will be as big a growth catalyst for supermarket pharmacies as it will be for their pureplay drug store cousins, Credit Suisse research analyst Ed Kelly stated in a note published Thursday.

February 1, 2011

Optivia Biotechnology on Tuesday announced that the company and the Food and Drug Administration have signed a collaboration agreement to assess the effect of dietary supplements on key drug transporters.

January 10, 2011

A leading wholesale distributor of prescription and over-the-counter pharmaceuticals announced the retirement of its CEO.

January 10, 2011

PakSense has launched a small device for monitoring the temperatures of medicines, the company said Monday.

January 5, 2011

CHICAGO — At first glance, there doesn’t seem a natural connection between the CD-ROM version of “Who Wants To Be A Millionaire?” and health education. But one company’s smashing success with interactive games led to its venture into prevention and disease management.